Effective January 1, 2017, CVS Caremark will add Buprenorphine/Opioid to its DUR edits. Buprenorphine sublingual (SL) tablets and buprenorphine/naloxone SL film/tablets are indicated for the treatment of opioid dependency. Use of these products should be part of a complete treatment plan, which includes counseling and psychosocial support.
*Please see attached PDF for more information.